The global demand for Xanthohumol Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020- 2026.
Xanthohumol is the prenylated flavonoid found in the female inflorescences of Humulus lupulus, also known as hop plant. In recent years, various researches revealed the beneficiary effects of xanthohumol including antioxidant properties, anti-inflammatory, hypoglycemic activities, and anticancer effects. Xnathohumol is also potential in the treatment of dysregulation of glucose metabolism, obesity, and hepatic steatosis. Similarly, it is also found that xanthohumol is able to reduce body weight in humans. Xanthohumol is majorly used as a cancer preventative that restricts the metabolic activity of procarcinogens coupled with early stage tumor growth.
According to the research study by National Cancer Institute, it is estimated that 1,735,350 new cases of cancer will be diagnosed in the U.S and 609,640 people will die from the disease. Moreover, according to the study, 15,270 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,790 died of the disease. In the U.S, national expense for cancer is rapidly increasing on every year. For the past few years there has been an increasing interest in the phenolic compounds owing to its benefits in the prevention of various degenerative diseases, such as cancer and cardiovascular diseases. Xanthohumol increases the expression of phase II cytoprotective enzymes, thereby inactivating carcinogens. This agent exerts anti-inflammatory activities, by inhibiting the inflammation-inducing enzymes, which in turn inhibits DNA synthesis, and induces apoptosis of susceptible cancer cells.
Xanthohumol also lowers the expression of C-X-C chemokine receptor 4 (CXCR4), and hence prevents the cancer cell invasion. In the recent years, xanthohumol is gaining momentum owing to its wide range of biologic properties that has therapeutic utilities. Attributed to the health benefits of xanthohumol, the production beer enriched with this substance is of huge interest in the brewing industry as it also contributes to the consumer health as well. Therefore, the aforementioned factors are increasing the usage of xanthohumol, thereby boosting the market growth. Moreover, upon administration, xanthohumol scavenges reactive oxygen species (ROS), and hence prevents DNA damage caused by the oxidative stress. In addition to this, laboratory studies also revealed the benefits of xanthohumol in the body weight reduction and its role in improving the gut barrier defenses. Hence, it is estimated that xanthohumol market will be growing in a faster pace during the forecast timeline.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Xanthohumol.
The entire Xanthohumol market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Food Industry
- Pharmaceutical Industry
This section covers regional segmentation which accentuates on current and future demand for Xanthohumol market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Xanthohumol Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Xanthohumol market include GLOMEX, Xi'an Sonwu Biotech, Organic Herb, Xi'an Hao-Xuan Bio-Tech, Xi'an, ArisunChemPharm, Xian Sost Biotech, and Xian Plant Bio-Engineering.. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.